We are live on ! Find out more
PBM

Propel Bio Management Portfolio holdings

AUM $191M Turnover 36.59%
1-Year Est. Return 102.42%
This Fund
S&P 500
This Quarter Est. Return
-8.08%
1 Year Est. Return
+102.42%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$17.6M
Cap. Flow
-$217K
Cap. Flow %
-0.14%
Top 10 Hldgs %
83.26%
Holding
32
New
4
Increased
4
Reduced
–
Closed
8
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
PAGP icon
Plains GP Holdings
PAGP
+$25.2M
2
ABEO icon
Abeona Therapeutics
ABEO
+$6.37M
3
VRCA icon
Verrica Pharmaceuticals
VRCA
+$3.26M
4
ARDX icon
Ardelyx
ARDX
+$2.32M
5
APLT icon
Applied Therapeutics
APLT
+$2.16M

Top Sells

Rank Stock Value
1
HIGH icon
Simplify Enhanced Income ETF
HIGH
+$28M
2
DAWN icon
Day One Biopharmaceuticals
DAWN
+$4.47M
3
MBB icon
iShares MBS ETF
MBB
+$2.07M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$1.76M
5
MRNS icon
Marinus Pharmaceuticals, Inc
MRNS
+$1.63M

Sector Composition

Rank Sector Weight
1 Healthcare 79.89%
2 Energy 16.75%
3 Technology 2.16%
4 Miscellaneous 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MIRM icon
26
Mirum Pharmaceuticals
MIRM
$5.2B
– –
-70,000
Closed -$1.76M –
STRO icon
27
Sutro Biopharma
STRO
$188M
– –
-19,500
Closed -$1.1M –
XFOR icon
28
X4 Pharmaceuticals
XFOR
$260M
– –
-17,833
Closed -$744K –
MRNS icon
29
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-180,100
Closed -$1.63M –
1
2

Similar funds

CFG
Capital Financial Group Greenwood Village, Colorado $191M AUM
ALWM
Andrews Lucia Wealth Management Danville, California $191M AUM 24.94% 1-Year Est. Return
PFA
Pillar Financial Advisors Louisville, Kentucky $191M AUM 21.21% 1-Year Est. Return
NWM
Navigoe Wealth Management Redondo Beach, California $191M AUM 25.21% 1-Year Est. Return
EMCIP
Ewing Morris & Co Investment Partners Toronto, Ontario, Canada $191M AUM 23.88% 1-Year Est. Return
HPM
H. Partners Management New York $191M AUM 5.95% 1-Year Est. Return
SFP
Strategic Financial Planning Plano, Texas $192M AUM 20.45% 1-Year Est. Return
PFA
Presper Financial Architects Akron, Ohio $192M AUM 21.89% 1-Year Est. Return

Propel Bio Management's Q2 2024 Portfolio in Review

As of Q2 2024, Propel Bio Management held 32 positions worth $154M, down 10% from $172M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Propel Bio Management's Q2 2024 filing shows 4 new, 4 increased and 8 closed positions. Its largest new stake was Plains GP Holdings: 1,372,360 shares worth $25.8M. The largest sale was Simplify Enhanced Income ETF, an estimated $28M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 80% a quarter earlier, followed by Energy and Technology.

  • Propel Bio Management's largest Q2 2024 buy was Plains GP Holdings: 1,372,360 shares worth $25.8M.
  • Propel Bio Management added most to Ardelyx in Q2 2024, an estimated $2.32M increase.
  • Propel Bio Management fully exited Simplify Enhanced Income ETF in Q2 2024, selling an estimated $28M.
  • Propel Bio Management's ten largest holdings make up 83% of its $154M portfolio in Q2 2024.
  • Propel Bio Management opened 4 new positions and closed 8 in Q2 2024.
  • Propel Bio Management's portfolio value fell 10% quarter-over-quarter to $154M.

Based on Propel Bio Management's 13F filing for Q2 2024, filed 12 Aug 2024.